PROCTER & GAMBLE HEALTH | ZIM LABORATORIES | PROCTER & GAMBLE HEALTH/ ZIM LABORATORIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 36.3 | 95.2% | View Chart |
P/BV | x | 10.6 | 3.0 | 354.9% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH ZIM LABORATORIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
ZIM LABORATORIES Mar-23 |
PROCTER & GAMBLE HEALTH/ ZIM LABORATORIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 388 | 1,382.9% | |
Low | Rs | 3,883 | 67 | 5,756.9% | |
Sales per share (Unadj.) | Rs | 740.7 | 81.8 | 905.7% | |
Earnings per share (Unadj.) | Rs | 138.2 | 5.0 | 2,756.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 8.6 | 1,804.4% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 41.1 | 1,088.7% | |
Shares outstanding (eoy) | m | 16.60 | 48.73 | 34.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.8 | 224.2% | |
Avg P/E ratio | x | 33.5 | 45.4 | 73.7% | |
P/CF ratio (eoy) | x | 29.8 | 26.5 | 112.5% | |
Price / Book Value ratio | x | 10.3 | 5.5 | 186.5% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 11,096 | 691.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 493 | 418.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 3,985 | 308.5% | |
Other income | Rs m | 184 | 64 | 286.8% | |
Total revenues | Rs m | 12,480 | 4,049 | 308.2% | |
Gross profit | Rs m | 3,247 | 520 | 624.6% | |
Depreciation | Rs m | 281 | 175 | 160.9% | |
Interest | Rs m | 8 | 56 | 13.8% | |
Profit before tax | Rs m | 3,142 | 354 | 888.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 109 | 775.8% | |
Profit after tax | Rs m | 2,295 | 244 | 939.1% | |
Gross profit margin | % | 26.4 | 13.0 | 202.4% | |
Effective tax rate | % | 27.0 | 30.9 | 87.3% | |
Net profit margin | % | 18.7 | 6.1 | 304.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,909 | 613.4% | |
Current liabilities | Rs m | 6,791 | 1,108 | 613.0% | |
Net working cap to sales | % | 40.0 | 20.1 | 199.0% | |
Current ratio | x | 1.7 | 1.7 | 100.1% | |
Inventory Days | Days | 263 | 19 | 1,348.7% | |
Debtors Days | Days | 343 | 872 | 39.4% | |
Net fixed assets | Rs m | 10,617 | 1,569 | 676.6% | |
Share capital | Rs m | 166 | 487 | 34.1% | |
"Free" reserves | Rs m | 7,265 | 1,516 | 479.1% | |
Net worth | Rs m | 7,431 | 2,003 | 370.9% | |
Long term debt | Rs m | 0 | 246 | 0.0% | |
Total assets | Rs m | 22,330 | 3,479 | 641.9% | |
Interest coverage | x | 409.1 | 7.3 | 5,571.6% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 0.6 | 1.1 | 48.1% | |
Return on assets | % | 10.3 | 8.6 | 119.5% | |
Return on equity | % | 30.9 | 12.2 | 253.2% | |
Return on capital | % | 42.4 | 18.2 | 233.0% | |
Exports to sales | % | 0 | 81.1 | 0.0% | |
Imports to sales | % | 13.1 | 12.2 | 107.2% | |
Exports (fob) | Rs m | NA | 3,230 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 485 | 330.8% | |
Fx inflow | Rs m | 1,465 | 3,281 | 44.7% | |
Fx outflow | Rs m | 1,605 | 485 | 330.8% | |
Net fx | Rs m | -140 | 2,796 | -5.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 375 | 629.0% | |
From Investments | Rs m | -215 | -362 | 59.4% | |
From Financial Activity | Rs m | -985 | 5 | -18,034.8% | |
Net Cashflow | Rs m | 1,160 | 30 | 3,867.7% |
Indian Promoters | % | 0.0 | 33.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 199,700.0% | |
FIIs | % | 6.2 | 0.0 | 62,400.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 66.7 | 72.2% | |
Shareholders | 56,778 | 17,100 | 332.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | ZIM LABORATORIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -1.38% | 0.45% |
1-Month | -1.15% | 26.33% | 2.55% |
1-Year | 0.73% | 54.35% | 56.14% |
3-Year CAGR | -8.76% | 7.22% | 15.22% |
5-Year CAGR | 4.97% | -0.49% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the ZIM LABORATORIES share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of ZIM LABORATORIES the stake stands at 33.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of ZIM LABORATORIES.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
ZIM LABORATORIES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of ZIM LABORATORIES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.